Malaysia in Focus - ARNI Data and its Implications on Clinical Practice
Published: 09 September 2020
-
Views:
2625 -
Likes:
7
-
Views:
2625 -
Likes:
7
-
Up Next
-
8m 35sPart 3 | Session 4 When to Initiate ARNI Therapy in Acute Heart Failure
-
2m 19sPart 3 | Session 5 Summary
-
31m 13sPart 1 | Session 1 Meet the Expert Presentation Carolyn Lam, Wan Azman Wan Ahmad
-
27m 18sPart 1 | Session 2 Meet the Expert Q&A Carolyn Lam, Wan Azman Wan Ahmad
-
3m 47sPart 2 Expert Interview Carolyn Lam
-
5m 28sPart 3 | Session 1 Local Interpretation of Emerging ARNI Data in HF Azmee Mohd Ghazi
-
18m 26sPart 3 | Session 2 ARNI Therapy Mode of Action Azmee Mohd Ghazi, James L Januzzi, Akshay S Desai
Overview
This educational programme focuses on placing recent data on ARNIs in Heart Failure into perspective for a Malaysian audience
More from this programme
Part 1
Local Interpretation of Emerging ARNI Data in HF
Part 2
Managing Hypotension in Patients with HFrEF (Utilising ARNIs)
1 session | |
Expert Interview | Watch now |
Part 3
Clinical Questions on ARNI therapy
Faculty Biographies
Azmee Mohd Ghazi
Dr Azmee Mohd Ghazi is a Cardiologist at the National Heart Centre, Malaysia, where he serves as Clinical Director for Heart Failure and Heart Transplant. Specialising in coronary intervention, cardiac transplantation, advanced adult heart failure and pulmonary hypertension, Dr Azmee undertakes a number of procedures including coronary intervention (PCI), right heart catheterisation, and echocardiography.
David Morrow
Prof David A Morrow the Director of the Samuel A. Levine Cardiac Intensive Care Unit in the Division of Cardiovascular Medicine at Brigham and Women's Hospital and a Professor of Medicine at Harvard Medical School. He directs the TIMI Biomarker Program